Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis
Sarah Jafrin, Nura Ershad Naznin, Md. Sharif Reza, Md. Abdul Aziz, Mohammad Safiqul Islam
Topics & Concepts
MedicineClopidogrelCYP2C19Internal medicineMeta-analysisStroke (engine)Coronary artery diseaseRelative riskSubgroup analysisAlleleLower riskCardiologyGastroenterologyAspirinConfidence intervalGeneGeneticsCytochrome P450Mechanical engineeringBiologyMetabolismEngineeringAntiplatelet Therapy and Cardiovascular DiseasesEicosanoids and Hypertension PharmacologyPharmacogenetics and Drug Metabolism